Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (172)

Clear all filters
Clear all filters

Spebrutinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma/CLL)

Drug Class / Mechanism

BTK Inhibitor

Tafasitamab

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Hematologic

Drug Class / Mechanism

ADC

Tagraxofusp

Targeted Therapy (Antibody)

Therapeutic Category

Targeted Therapy (Antibody)

Oncology Type

Hematologic

Drug Class / Mechanism

CD123-Directed Diphtheria Toxin Fusion Protein

Tazemetostat

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

EZH2 / Menin Inhibitor

Thalidomide

Immunomodulatory Agent

Therapeutic Category

Immunomodulatory Agent

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

IMiD (Cereblon Modulator)

Tirabrutinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma/CLL)

Drug Class / Mechanism

BTK Inhibitor

Tisagenlecleucel

Cellular Therapy (CAR-T)

Therapeutic Category

Cellular Therapy (CAR-T)

Oncology Type

Hematologic (Leukemia/Lymphoma/Myeloma)

Drug Class / Mechanism

Chimeric Antigen Receptor T-Cell Therapy

Tucidinostat

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma)

Drug Class / Mechanism

HDAC Inhibitor

Ublituximab

Immunotherapy (Monoclonal Antibody)

Therapeutic Category

Immunotherapy (Monoclonal Antibody)

Oncology Type

Hematologic (Lymphoma/CLL)

Drug Class / Mechanism

Anti-CD20 mAb

Valemetostat

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

EZH2 / Menin Inhibitor

Vecabrutinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma/CLL)

Drug Class / Mechanism

BTK Inhibitor

Veltuzumab

Immunotherapy (Monoclonal Antibody)

Therapeutic Category

Immunotherapy (Monoclonal Antibody)

Oncology Type

Hematologic (Lymphoma/CLL)

Drug Class / Mechanism

Anti-CD20 mAb